Type 1 Diabetes (T1D) Clinical Trials

Find Type 1 Diabetes (T1D) Clinical Trials Near You

Achieving Health in Emerging Adults With Diabetes (AHEAD) Study

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to determine whether the Achieving Health in Emerging Adults with Diabetes (AHEAD) Program helps emerging adults with type 1 diabetes improve their blood glucose management during the transition from pediatric to adult care. Participants will be randomized to receive Usual Care or the AHEAD Program, which provides tailored support to emerging adults to build autonomy and competence to facilitate independent diabetes management. Researchers will compare changes in glycemia and participant-reported outcomes between groups.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Maximum Age: 19
Healthy Volunteers: f
View:

• 16-19 years of age

• Have had type 1 diabetes ≥ 12 months

• Had a recent HbA1c ≥7.0%

• Currently receive outpatient diabetes care at a Seattle Children's Hospital Diabetes Clinic located in Bellevue, Everett, Federal Way, or Seattle

• Are able to complete written surveys

• Will be able to receive clinical care in WA State for the next 2 years

Locations
United States
Washington
Seattle Children's
RECRUITING
Seattle
Contact Information
Primary
Beth Loots, MPH, MSW
beth.loots@seattlechildrens.org
206-884-4488
Backup
Faisal S Malik, MD, MSc
faisal.malik@bcchr.ca
604-875-2117
Time Frame
Start Date: 2025-12-15
Estimated Completion Date: 2028-12
Participants
Target number of participants: 306
Treatments
Experimental: AHEAD Program
AHEAD participants will receive support from a team of diabetes providers with expertise in supporting older adolescents and young adults who will work to build autonomy and competence needed to manage diabetes independently.
No_intervention: Usual Care
Usual Care participants will receive diabetes care as currently being provided by their primary medical team.
Related Therapeutic Areas
Sponsors
Collaborators: University of Washington, Breakthrough T1D, Seattle Children's Hospital, Kaiser Permanente
Leads: University of British Columbia

This content was sourced from clinicaltrials.gov